Escalon Medical Corp
Escalon Medical Corp. develops, manufactures, markets, and distributes ophthalmic medical devices and related products for eye-care procedures and diagnostics. Its portfolio includes ultrasound systems for biometric and diagnostic use, disposable surgical packs for vitreoretinal surgery, and the AXIS image management system for ophthalmic imaging workflows.
Fiscal year 2026 · change from previous year
Development 2021–2026
Business
Share of revenueA-Scan and B-Scan ultrasound devices and related software used for eye diagnostics and biometric measurements.
Disposable surgical packs used in vitreoretinal surgery, including silicone oil handling packs.
AXIS Image Management system for storing and accessing ophthalmic diagnostic images through a web browser.
Repairs, warranties, and remote support for ultrasound, imaging, and surgical products.
Products
Reported · share of revenue- Products94.9 %
- Services5.1 %
Source: 10-K FY2026, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Escalon sells primarily to medical institutions and eye-care providers that need diagnostic equipment, surgical consumables, and image management tools for ophthalmology workflows. Its customer base is served through independent sales representatives, distributors, and direct sales employees, which suggests a mix of hospital, clinic, and specialty practice end users. The company also supports installed customers with repair and service, which helps retain recurring relationships after the initial sale.
Buy ultrasound systems and image management tools to diagnose and monitor eye conditions.
Buy disposable surgical packs and silicone oil handling packs for procedure-specific use.
Place products into local healthcare markets and expand reach without a large direct field force.
Purchase repairs, service, and replacement support for previously installed systems.
Strategy
Escalon’s strategy centers on refreshing ophthalmic products, supporting its installed base, and using regulatory clearances such as FDA registration and CE Mark to sell into more markets. The company also appears focused on maintaining a broad product mix across ultrasound, surgical disposables, and imaging software to reduce reliance on any single product line.
R&D is tied to new and improved ophthalmic products that can drive adoption and offset mature product pressure.
CE Mark and other clearances allow the company to sell beyond the U.S. and diversify demand.
Repairs, warranties, and remote support help preserve installed-base relationships and recurring revenue.
Geography
Escalon sells throughout the United States and internationally, with 56.0% of fiscal 2025 revenue generated domestically and 44.0% from foreign markets. The company manufactures and assembles ophthalmic surgical products in New Berlin, Wisconsin, and designs, assembles, and services ultrasound products in Lake Success, New York, so its operating footprint is concentrated in the U.S. while sales are globally distributed.
Risks
Escalon faces meaningful execution and balance-sheet risk because it has a history of operating losses and management has disclosed substantial doubt about going concern. Its business is also exposed to regulatory, product liability, cybersecurity, and supply-chain risks, all of which can disrupt sales or raise costs in a small medical-device platform. Dependence on a few customers and suppliers adds concentration risk to an already narrow product base.
- Going concern and liquidity pressureImpact: CriticalLikelihood: High
The company has a history of operating losses and disclosed substantial doubt about continuing as a going concern.
Exposure: Cash to current liabilities and ability to raise capital
- Regulatory approval and complianceImpact: HighLikelihood: Medium
Medical devices require FDA and foreign clearances, and changes in rules can delay launches or restrict sales.
Exposure - Product liabilityImpact: HighLikelihood: Low
Surgical and diagnostic products can create claims if defects or performance issues occur.
Exposure: Ophthalmic surgical packs and ultrasound systems
- Customer and supplier concentrationImpact: HighLikelihood: Low
A small number of customers and suppliers can materially affect sales, receivables, and production continuity.
Exposure: Top customer and key component vendors
- Cybersecurity and data privacyImpact: MediumLikelihood: Low
The company uses internet-based systems and stores confidential customer and employee data.
Exposure: AXIS image management and internal IT systems
Accounting
Judgemental itemsProduct revenue and service-plan revenue move differently and can change reported margins.
Impact: Affects quarterly comparability and gross margin
Management must assess whether cash resources and future operations support continued operations.
Impact: Can influence disclosures and valuation assumptions
Customer concentration and dispersed international sales require judgment on collectability.
Impact: Affects net revenue and working capital
Medical-device products require estimates for obsolescence, returns, and warranty obligations.
Impact: Affects cost of revenue and liabilities
The company operates from leased facilities in New Berlin and Lake Success.
Impact: Affects balance sheet assets and liabilities
Similar listed companies
Publicly listed companies with a comparable business focus.
Alcon Inc
ALC · Ophthalmic Goods
Alcon Inc is a United States-based ophthalmic goods company focused on eye care products and surgical ophthalmology solutions.
RetinalGenix Technologies Inc.
RTGN · Surgical & Medical Instruments & Apparatus
LENSAR, Inc.
LNSR · Surgical & Medical Instruments & Apparatus
Ocular Therapeutix, Inc
OCUL · Pharmaceutical Preparations
OSI Systems, Inc
OSIS · Semiconductors & Related Devices
STAAR Surgical Company
STAA · Ophthalmic Goods
STAAR Surgical designs, manufactures, and sells implantable lenses for the eye and the accessory delivery systems used to place them.
Last updated: 24/09/2026